Utilidad marginal de la escala SAMe-TT 2 R 2 en la predicción de la calidad de la anticoagulación oral con acenocumarol en el "mundo real"

Mora-Llabata, Vicente; Dubois-Marqués, Daniela; Moreno-Prat, Miriam; Platas-Valenciano, Jesús; Salavert-Nadal, María Teresa; Gasull-Inserte, Salvador; Pacheco-Arroyo, Julián; Roldán-Torres, Ildefonso.
Rev. colomb. cardiol ; 25(3): 185-191, mayo-jun. 2018. tab, graf
Artículo en Español | LILACS, COLNAL | ID: biblio-978224

Documentos relacionados

  1. [Switching from acenocoumarol to phenprocoumon: step in personalised anticoagulation?]
  2. [Anticoagulant efficacy of different pharmacological presentations of vitamin K antagonists].
  3. Análisis farmacogenético retrospectivo de una paciente pediátrica en tratamiento anticoagulante: caso clínico
  4. More precise dosing of acenocoumarol for better control in patients aged above 80 years, a randomised controlled pilot study.
  5. Introducing the "Bleeding Team": Urgent Reconstruction of an Open Fracture in a Patient Receiving Acenocoumarol: A Case Report.
  6. Oral anticoagulant therapy and bleeding events with vitamin K antagonists in patients with atrial fibrillation in a Hungarian county hospital.
  7. [Introduction of acenocoumarol using an algorithm for prescription].
  8. Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation.
  9. Biomodification of acenocoumarol by bifidobacteria.
  10. A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment.